|
|
 |
|
Viewing report
|
|
|
|
H. Lundbeck A/S: PharmaVitae Profile
Datamonitor, Dec 2010, Pages: 58
Introduction
This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
- Gain insight into Lundbeck's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Highlights
Strategic insight into the prospects for Lundbeck over the next six years.
Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
- Benchmark Lundbeck's performance against key rivals in the prescription pharmaceutical sector
- Assess the company's position versus key rivals in its core CNS focus market
- Analyze how Lundbeck has increasingly used externalization strategies to both boost R&D productivity and enhance its geographic footprint
|
|
|
|
